Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand

被引:57
|
作者
Ngamvithayapong, J
Uthaivoravit, W
Yanai, H
Akarasewi, P
Sawanpanyalert, P
机构
[1] RES INST TB,KIYOSE,TOKYO 204,JAPAN
[2] CHULALONGKORN UNIV,COLL PUBL HLTH,BANGKOK,THAILAND
[3] MINIST PUBL HLTH,CHIANG RAI REG HOSP,CHIANG MAI,THAILAND
[4] TENTH TB ZONAL CTR,CHIANG MAI,THAILAND
[5] MINIST PUBL HLTH,DEPT MED SERV,NONTHABURI,THAILAND
关键词
tuberculosis; preventive therapy; asymptomatic HIV infection; adherence; Thailand;
D O I
10.1097/00002030-199701000-00016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To determine the level of and reasons associated with adherence to tuberculosis preventive therapy among asymptomatic HIV-infected individuals in northern Thailand. Design: A prospective cohort study with a 9-month follow-up. Methods: A total of 412 HIV-infected persons were enrolled in a tuberculosis preventive therapy programme in a hospital. A 9-month isoniazid regimen was prescribed. Adherence was determined by pill count. Participants who missed a scheduled appointment for more than a month were interviewed. Five focus group discussion sessions were held among those who successfully completed the therapy. Results: Of the 412 participants, 69.4% (286) completed the 9-month regimen. The adherence rate, defined as the proportion of those who took more than 80% of pills, was 67.5% (n=278). Sex, source of participants and history of physical symptoms were associated with adherence. A significant portion of defaults took place at the beginning of the therapy. Out-migration, denial of HIV status, and perceived side effects of isoniazid were frequently cited as reasons for non-adherence. For those adhering participants, the acceptance of personal HIV status, concern about children and family, and a good health provider relationship were important reasons motivating adherence. Several reminder systems were developed by the participants. Conclusions: Although an isoniazid preventive therapy programme was shown to be feasible, further adjustments on the selection of participants, enrolment process, and follow-up system based on these findings are necessary to increase the adherence.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 50 条
  • [1] Acceptability of Carraguard Vaginal Microbicide Gel among HIV-Infected Women in Chiang Rai, Thailand
    Whitehead, Sara J.
    McLean, Catherine
    Chaikummao, Supaporn
    Braunstein, Sarah
    Utaivoravit, Wat
    van de Wijgert, Janneke H.
    Mock, Philip A.
    Siraprapasiri, Taweesap
    Friedland, Barbara A.
    Kilmarx, Peter H.
    Markowitz, Lauri E.
    PLOS ONE, 2011, 6 (09):
  • [2] Causes of mortality among tuberculosis and HIV co-infected patients in Chiang Rai, Northern Thailand
    Kantipong, Pacharee
    Murakami, Kuniko
    Moolphate, Saiyud
    Aung, Myo Nyein
    Yamada, Norio
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2012, 4 : 159 - 168
  • [3] Tuberculosis preventive therapy for HIV-infected persons in less developed countries
    Kritski, AL
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2000, 4 (02) : S76 - S81
  • [4] INH preventive therapy among adult HIV-infected patients in Thailand
    Hiransuthikul, N
    Nelson, KE
    Hiransuthikul, P
    Vorayingyong, A
    Paewplot, R
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (03) : 270 - 275
  • [5] Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study
    Antonucci, G
    Girardi, E
    Raviglione, M
    Vanacore, P
    Angarano, G
    Chirianni, A
    Pagano, G
    Suter, F
    Lauria, FN
    Ippolito, G
    EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (02) : 369 - 375
  • [6] Tuberculosis preventive therapy in HIV-infected persons: feasibility issues in developing countries
    Hawken, MP
    Muhindi, DW
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1999, 3 (08) : 646 - 650
  • [7] PREVENTIVE THERAPY FOR TUBERCULOSIS IN HIV-INFECTED PERSONS - INTERNATIONAL RECOMMENDATIONS, RESEARCH, AND PRACTICE
    DECOCK, KM
    GRANT, A
    PORTER, JDH
    LANCET, 1995, 345 (8953): : 833 - 836
  • [8] Transaminitis prevalence among HIV-infected adults eligible for tuberculosis preventive therapy
    Chaisson, Lelia H.
    Semitala, Fred C.
    Mwebe, Sandra
    Katende, Jane
    Asege, Lucy
    Nakaye, Martha
    Andama, Alfred O.
    Atuhumuza, Elly
    Kamya, Moses
    Cattamanchi, Adithya
    Yoon, Christina
    AIDS, 2022, 36 (11) : 1591 - 1595
  • [9] Causes of Death in HIV-infected Persons Who Have Tuberculosis, Thailand
    Cain, Kevin P.
    Anekthananon, Thanomsak
    Burapat, Channawong
    Akksilp, Sornsalk
    Mankhatitham, Wiroj
    Srinalk, Chawin
    Nateniyom, Sriprapa
    Sattayawuthipong, Wanchai
    Tasaneeyapan, Theerawit
    Varma, Jay K.
    EMERGING INFECTIOUS DISEASES, 2009, 15 (02) : 258 - 264
  • [10] Knowledge, attitudes and beliefs regarding tuberculosis preventive therapy for HIV-infected persons, Botswana, 1999
    Talbot, EA
    Kenyon, TA
    Halabi, S
    Moeti, TL
    More, K
    Binkin, NJ
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2000, 4 (12) : 1156 - 1163